Membrane-camouflaged liposomes Co-delivering L-Arg and NMN for reprogramming macrophage nitric oxide metabolism in atherosclerosis
Journal of Biomaterials Applications · 12.08.2026
DOI: 10.1177/08853282261476791 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Biomaterials Applications, online erschienen am 12.08.2026. Verfasst von Xuting Li und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Shangyu People's Hospital of Shaoxing, Shaoxing, China. Die Arbeit nennt 23 Literaturangaben. Gefördert von: Zhejiang Provincial Administration of Traditional Chinese Medicine Science and Technology Project.
Abstract (Originalsprache)
Atherosclerosis progression is closely linked to metabolic dysfunction of plaque macrophages, where inducible nitric oxide synthase (iNOS)-mediated pathological nitric oxide (NO) burst is a key driver of inflammation and oxidative stress. This study designed macrophage membrane-camouflaged liposomes (M-AN@Lip) for the co-delivery of nicotinamide mononucleotide (NMN) and L-arginine (L-Arg), aiming to precisely regulate macrophage NO metabolic homeostasis. In vitro experiments demonstrated that M-AN@Lip effectively increased intracellular NO generation while significantly downregulating the expression of the oxidative stress-related enzyme NAD(P)H quinone oxidoreductase 1 (NQO1), suggesting a reprogramming of macrophage NO metabolism from a pathological iNOS-dominated pathway towards a protective one. This metabolic shift was accompanied by clearance of intracellular reactive oxygen species (ROS), enhancement of the endogenous antioxidant enzyme system, and polarization of macrophages towards an anti-inflammatory M2 phenotype. Ultimately, M-AN@Lip significantly inhibited oxidized low-density lipoprotein (ox-LDL) uptake and foam cell formation by downregulating the expression of scavenger receptors (CD36, MSR1, SRB1). This study demonstrates that a biomimetic nano-system can achieve integrated anti-inflammatory, antioxidant, and anti-foam cell forming effects through the synergistic regulation of NO metabolism, offering a promising novel nanotherapeutic strategy for atherosclerosis.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Neurology, Shangyu People's Hospital of Shaoxing, Shaoxing, China.
- School of Medicine, Shaoxing University, Shaoxing, China.
- Department of Neurosurgery,Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, China.
ORCID-Profile: Zhenlei Jia
Förderung
- Zhejiang Provincial Administration of Traditional Chinese Medicine Science and Technology Project
Zitieren
APA
Li, X., Yuan, Y., Lian, C., Zhu, D., Wang, Y., & Jia, Z. (2026). Membrane-camouflaged liposomes Co-delivering L-Arg and NMN for reprogramming macrophage nitric oxide metabolism in atherosclerosis. Journal of Biomaterials Applications. https://doi.org/10.1177/08853282261476791
Vancouver
Li X, Yuan Y, Lian C, Zhu D, Wang Y, Jia Z. Membrane-camouflaged liposomes Co-delivering L-Arg and NMN for reprogramming macrophage nitric oxide metabolism in atherosclerosis. Journal of Biomaterials Applications. 2026. doi:10.1177/08853282261476791
BibTeX
@article{Li2026,
author = {Li, Xuting and Yuan, Yi and Lian, Changhong and Zhu, Dongdong and Wang, Yan and Jia, Zhenlei},
title = {Membrane-camouflaged liposomes Co-delivering L-Arg and NMN for reprogramming macrophage nitric oxide metabolism in atherosclerosis},
journal = {Journal of Biomaterials Applications},
year = {2026},
doi = {10.1177/08853282261476791}
}
EUVIMED